Old drug, new hope: could 4-AP save carpal tunnel patients from surgery?
NCT ID NCT06294821
First seen Sep 30, 2025 · Last updated May 21, 2026 · Updated 33 times
Summary
This study tests whether 4-aminopyridine, a drug already approved by the FDA for other uses, can relieve symptoms of carpal tunnel syndrome or delay the need for surgery. About 160 adults with carpal tunnel who would normally have surgery will take the drug twice daily for 6 weeks. Researchers will track symptom changes using standard hand-function questionnaires and nerve tests over 56 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPRESSION NEUROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.